Extrawell Pharmaceutical Holdings Ltd

HKSE:00858 (Hong Kong)  
HK$ 0.05 (+1.92%) Nov 29
On watch
At Loss
P/B:
0.11
Market Cap:
HK$ 126.67M ($ 16.28M)
Enterprise V:
HK$ 152.81M ($ 19.64M)
Volume:
880.00K
Avg Vol (2M):
2.63M
Warning! GuruFocus detected 3 Severe warning signs with 00858. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
880.00K
Market Cap HK$:
126.67M
Market Cap $:
16.28M
At Loss
Avg Vol (2M):
2.63M
Enterprise Value HK$:
152.81M
Enterprise Value $:
19.64M
PB Ratio:
0.11
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Extrawell Pharmaceutical Holdings Ltd
NAICS : 325412
ISIN : BMG3285Q1134
http://www.extrawell.com.hk
979 King’s Road, Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, Quarry Bay, Hong Kong, HKG
Compare
Compare
HKSE:00575HKSE:01312HKSE:08622HKSE:01011HKSE:01889HKSE:00911HKSE:08329HKSE:00897HKSE:01498HKSE:00455ZTSXTER:MRKNSE:SUNPHARMALSE:HLNTSE:4502XSWX:GALDXSWX:SDZXTAE:TEVANSE:DIVISLABVTRS
Traded in other countries / regions
00858.Hong Kong
IPO Date
1999-10-03
Description
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.78
Equity-to-Asset 0.87
Debt-to-Equity 0.11
Debt-to-EBITDA -0.86
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.68
Distress
Grey
Safe
Beneish M-Score -3.05
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -8.8
3-Year EBITDA Growth Rate -9.4
3-Year EPS without NRI Growth Rate -46.2
3-Year FCF Growth Rate -26
3-Year Book Growth Rate 2.6

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 49.85
9-Day RSI 52.6
14-Day RSI 53.86
6-1 Month Momentum % 19.51
12-1 Month Momentum % 40

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.45
Quick Ratio 3.31
Cash Ratio 1.84
Days Inventory 63.59
Days Sales Outstanding 31.64
Days Payable 68.5

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -16.01

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 48.7
Operating Margin % -11.04
Net Margin % -275.73
FCF Margin % -6.24
ROE % -14.23
ROA % -12.42
ROIC % -0.56
ROC (Joel Greenblatt) % -107.8
ROCE % -11.18
Years of Profitability over Past 10-Year 8

GF Value Rank

Name Current Vs Industry Vs History
Shiller PE Ratio 1.77
PS Ratio 2.12
PB Ratio 0.11
Price-to-Tangible-Book 0.11
EV-to-EBIT -1.07
EV-to-EBITDA -1.07
EV-to-Revenue 2.55
EV-to-FCF -38.18
Price-to-Projected-FCF 0.16
Price-to-Median-PS-Value 0.44
Earnings Yield (Greenblatt) % -93.46
FCF Yield % -2.91
Forward Rate of Return (Yacktman) % 1.15

Financials

HKSE:00858's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Extrawell Pharmaceutical Holdings Ltd Executives

Details

GF Value: HK$0.07

HKSE:00858

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 59.098
EPS (TTM) (HK$) -0.069
Beta 0.34
Volatility % 74.37
14-Day RSI 53.86
14-Day ATR (HK$) 0.003928
20-Day SMA (HK$) 0.0516
12-1 Month Momentum % 40
52-Week Range (HK$) 0.026 - 0.074
Shares Outstanding (Mil) 2,390

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Extrawell Pharmaceutical Holdings Ltd Filings

Filing Date Document Date Form
No Filing Data

Extrawell Pharmaceutical Holdings Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Extrawell Pharmaceutical Holdings Ltd Frequently Asked Questions

What is Extrawell Pharmaceutical Holdings Ltd(HKSE:00858)'s stock price today?
The current price of HKSE:00858 is HK$0.05. The 52 week high of HKSE:00858 is HK$0.07 and 52 week low is HK$0.03.
When is next earnings date of Extrawell Pharmaceutical Holdings Ltd(HKSE:00858)?
The next earnings date of Extrawell Pharmaceutical Holdings Ltd(HKSE:00858) is .
Does Extrawell Pharmaceutical Holdings Ltd(HKSE:00858) pay dividends? If so, how much?
Extrawell Pharmaceutical Holdings Ltd(HKSE:00858) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.